LIVERAMP HOLDINGS INC (RAMP)

US53815P1084 - Common Stock

33.16  0 (0%)

After market: 33.16 0 (0%)

Fundamental Rating

6

RAMP gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 277 industry peers in the Software industry. While RAMP has a great health rating, there are worries on its profitability. RAMP is not priced too expensively while it is growing strongly. Keep and eye on this one!



3

1. Profitability

1.1 Basic Checks

In the past year RAMP was profitable.
RAMP had a positive operating cash flow in the past year.
RAMP had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: RAMP reported negative operating cash flow in multiple years.

1.2 Ratios

With a decent Return On Assets value of -1.15%, RAMP is doing good in the industry, outperforming 63.04% of the companies in the same industry.
RAMP's Return On Equity of -1.49% is fine compared to the rest of the industry. RAMP outperforms 65.94% of its industry peers.
Industry RankSector Rank
ROA -1.15%
ROE -1.49%
ROIC N/A
ROA(3y)-6.56%
ROA(5y)8.12%
ROE(3y)-8.12%
ROE(5y)8.3%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

RAMP has a Gross Margin of 72.47%. This is in the better half of the industry: RAMP outperforms 62.32% of its industry peers.
RAMP's Gross Margin has improved in the last couple of years.
RAMP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 72.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.08%
GM growth 5Y4.93%

9

2. Health

2.1 Basic Checks

RAMP does not have a ROIC to compare to the WACC, probably because it is not profitable.
RAMP has less shares outstanding than it did 1 year ago.
The number of shares outstanding for RAMP has been reduced compared to 5 years ago.
There is no outstanding debt for RAMP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

RAMP has an Altman-Z score of 7.30. This indicates that RAMP is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 7.30, RAMP is doing good in the industry, outperforming 78.26% of the companies in the same industry.
There is no outstanding debt for RAMP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 7.3
ROIC/WACCN/A
WACC9.91%

2.3 Liquidity

A Current Ratio of 3.69 indicates that RAMP has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.69, RAMP belongs to the top of the industry, outperforming 80.07% of the companies in the same industry.
A Quick Ratio of 3.69 indicates that RAMP has no problem at all paying its short term obligations.
RAMP has a better Quick ratio (3.69) than 80.07% of its industry peers.
Industry RankSector Rank
Current Ratio 3.69
Quick Ratio 3.69

7

3. Growth

3.1 Past

RAMP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 179.63%, which is quite impressive.
RAMP shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -1.54% yearly.
The Revenue has been growing slightly by 7.95% in the past year.
RAMP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.07% yearly.
EPS 1Y (TTM)179.63%
EPS 3YN/A
EPS 5Y-1.54%
EPS growth Q2Q67.86%
Revenue 1Y (TTM)7.95%
Revenue growth 3Y16.16%
Revenue growth 5Y22.07%
Revenue growth Q2Q9.63%

3.2 Future

The Earnings Per Share is expected to grow by 22.68% on average over the next years. This is a very strong growth
Based on estimates for the next years, RAMP will show a quite strong growth in Revenue. The Revenue will grow by 11.35% on average per year.
EPS Next Y72.14%
EPS Next 2Y38.01%
EPS Next 3Y34%
EPS Next 5Y22.68%
Revenue Next Year8.52%
Revenue Next 2Y9.23%
Revenue Next 3Y10.24%
Revenue Next 5Y11.35%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 21.96 indicates a rather expensive valuation of RAMP.
RAMP's Price/Earnings ratio is rather cheap when compared to the industry. RAMP is cheaper than 83.33% of the companies in the same industry.
RAMP's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.15.
Based on the Price/Forward Earnings ratio of 20.01, the valuation of RAMP can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of RAMP indicates a rather cheap valuation: RAMP is cheaper than 80.43% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.20, RAMP is valued at the same level.
Industry RankSector Rank
PE 21.96
Fwd PE 20.01

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as RAMP.
Based on the Price/Free Cash Flow ratio, RAMP is valued cheaper than 85.51% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.66
EV/EBITDA 173.74

4.3 Compensation for Growth

RAMP's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
RAMP's earnings are expected to grow with 34.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.3
PEG (5Y)N/A
EPS Next 2Y38.01%
EPS Next 3Y34%

0

5. Dividend

5.1 Amount

No dividends for RAMP!.
Industry RankSector Rank
Dividend Yield N/A

LIVERAMP HOLDINGS INC

NYSE:RAMP (5/17/2024, 7:22:39 PM)

After market: 33.16 0 (0%)

33.16

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.19B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 21.96
Fwd PE 20.01
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.3
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.15%
ROE -1.49%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 72.47%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.69
Quick Ratio 3.69
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)179.63%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y72.14%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)7.95%
Revenue growth 3Y16.16%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y